3 Potential Catalysts That Could Lift Pfizer Stock Before 2025

The pipeline could yield a winner, but so could a few organizational changes.With the total return of Pfizer's (PFE -0.74%) shares rising by just 1.9% this year so far, investors may be yearning for some kind of catalyst that will stimulate its stock price to rise at a better pace.They're in luck. Three such catalysts are coming in the next couple of months (likely before 2025 starts) that could precipitate some market movement for the stock. Let's take a look at each.1. A phase 1 trial for a key obesity pr ...